Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $7.32 Billion
- Q3 2025
A detailed history of Avoro Capital Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 1,833,000 shares of MDGL stock, worth $970 Million. This represents 11.49% of its overall portfolio holdings.
Number of Shares
1,833,000
Previous 1,875,000
2.24%
Holding current value
$970 Million
Previous $567 Million
48.16%
% of portfolio
11.49%
Previous 10.35%
Shares
22 transactions
Others Institutions Holding MDGL
# of Institutions
406Shares Held
23.1MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$959 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...